Clinical Trial Update: A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating romiplostim for refractory transfusion-dependent aplastic anemia; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia | Phase 4 | Status: NOT_YET_RECRUITING